Weed Week: Cannabis may be the answer for this wilting WA coal mining town

“There’s a lot happening in the cannabis space, it’s quickly replacing the automobile industry by three times,” founder Rod Zakostelsky said.

“Obviously with the story around the mining industry on the downward slope and all the focus on diversification to sustain and build upon the town, this was a big driving force for our vision in Collie.”

In the last 12 months the Therapeutic Goods Administration (TGA) has granted 25,182 applications from doctors to prescribe cannabis-based drugs. This is 10 times more than in 2018.

Of these, the majority were for chronic pain and nearly half of them (10,000) were prescribed in the last three months.

That does not include people using medical cannabis illegally to self-medicate, which FreshLeaf Analytics placed at around 150,000 Australians.

Small cap spotlight

Below is Stockhead’s latest summary of weekly and annual price performance for ASX-listed cannabis stocks.

Scroll or swipe to reveal table. Click headings to sort.

This week the TGA granted THC Global Group (ASX:THC) the final manufacturing license it needed for its Southport facility. THC can now manufacture, package and test medical cannabis.

Roto-Gro International (ASX:RGI) harvested the first large scale cannabis crops from its rotational garden systems. It climbed 18 per cent this week.

Creso Pharma (ASX:CPH) was another winner after telling shareholders it made 700 per cent sales growth and had administered more than 3 million anibidiol hemp oil pet doses since it was launched in 2017.

Last week’s biggest winner, Elixinol Global (ASX:EXL) gained 67 per cent but did not have any news.